Sign in

CLB on NYSE

Core Laboratories

Logo: The logo is from the following website: https://www.corelab.com/ http://ewb.tamu.edu/getinvolved, Non-free logo, via Wikipedia5

American service Provider

Core Laboratories Inc ("Core Lab") is an American service provider of core and fluid analysis in the petroleum industry. Established in 1936, Core Lab is a global provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry.3 Its shares trade on NYSE under the symbol CLB.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1936Founded1

Compare with WaterBridge Infrastructure LLC, Ranger Energy Services, Inc. or Nine Energy Service, Inc., or pick any stock.

  • TickerCLB on NYSE1
  • Industrypetroleum industry1
  • HeadquartersHouston1
  • Websitewww.corelab.com
  • Legal formnaamloze vennootschap1
  • Incorporated inDE6
  • Business address6316 Windfern Road, Houston, Tx 770406
  • Filer categoryLarge accelerated filer6
  • LEI724500MDYY5VBSAF5W504
  • StatusInactive4
  • LEI statusRetired4
  • Registered addressVan Heuven Goedhartlaan 7B, 1181LE Amstelveen, Netherlands4
  • Registered withThe Netherlands Chamber of Commerce, 332611584

See how the biggest companies compare on our leaderboards

Core Laboratories Inc ("Core Lab") is an American service provider of core and fluid analysis in the petroleum industry. Established in 1936, Core Lab is a global provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

10.7%Operating margin9
5.6%Net margin9
0.5%Revenue growth, 20259
11.2%Return on equity9
0.41×Debt to equity9
$25.8MFree cash flow9

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Service brought in 76% of the revenue Core Laboratories broke down this way in fiscal 2025.

  1. Service$399.4M976%up 3% from 2024
  2. Product$127.1M924%down 6% from 2024
Products and services by year
Products and services202320242025
Service$371.9M$388.2M$399.4M
Product$137.9M$135.6M$127.1M

Business segments

Operating Segment Reservoir Description brought in 66% of the revenue Core Laboratories broke down this way in fiscal 2025.

  1. Operating Segment Reservoir Description$347.7M966%up 0% from 2024
  2. Operating Segment Production Enhancement$178.8M934%up 1% from 2024
Business segments by year
Business segments202320242025
Operating Segment Reservoir Description$333.3M$346.1M$347.7M
Operating Segment Production Enhancement$176.4M$177.7M$178.8M

Regions

Outside the United States brought in 67% of the revenue Core Laboratories broke down this way in fiscal 2025.

  1. Outside the United States$351.2M967%up 2% from 2024
  2. United States$175.3M933%down 2% from 2024
Regions by year
Regions202320242025
Outside the United States$331.2M$345.0M$351.2M
United States$178.5M$178.9M$175.3M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue79¢$417.6M
  • Other costs10¢$53.2M
  • Interest2¢$10.6M
  • Income tax3¢$15.5M
  • Profit6¢$29.7M

Out of $526.5M in revenue.9

Where each dollar of operating cash went, fiscal 2025

  • Capital spending30¢$11.2M
  • Dividends paid5¢$1.9M
  • Share buybacks34¢$12.4M
  • Kept or used elsewhere31¢$11.5M

Out of $37.0M of cash from operations.9

Financial statements

Revenue10119$526.5M in 2025+12% since 2021
0$200.0M$400.0M$600.0M2021: $470.3M$470.3M20212022: $489.7M$489.7M2022+4%2023: $509.8M$509.8M2023+4%2024: $523.8M$523.8M2024+3%2025: $526.5M$526.5M2025+1%
Operating income10119$56.5M in 2025+25% since 2021
0$20.0M$40.0M$60.0M2021: $45.3M$45.3M20212022: $41.5M$41.5M2022−8%2023: $54.6M$54.6M2023+32%2024: $58.6M$58.6M2024+7%2025: $56.5M$56.5M2025−4%
Net income10119$29.7M in 2025+50% since 2021
0$10.0M$20.0M$30.0M$40.0M2021: $19.7M$19.7M20212022: $19.5M$19.5M2022−1%2023: $36.7M$36.7M2023+89%2024: $31.4M$31.4M2024−14%2025: $29.7M$29.7M2025−6%

Every line of the income statement as filed: the last 3 fiscal years, latest first.9

Period ending2025-12-312024-12-312023-12-31
Revenue$526.5M$523.8M$509.8M
General and administrative expense, exclusive of depreciation expense shown below$45.4M$39.8M$40.3M
Depreciation$14.3M$14.4M$15.3M
Amortization$359.0K$504.0K$490.0K
Other (income) expense, net-$7.6M-$10.0M-$850.0K
OPERATING INCOME$56.5M$58.6M$54.6M
Interest expense$10.6M$12.4M$13.4M
Income before income taxes$45.9M$46.2M$41.2M
Income tax expense$15.5M$14.0M$4.2M
Net income$30.4M$32.2M$37.0M
Net income attributable to non-controlling interest$722.0K$753.0K$350.0K
Net income attributable to Core Laboratories Inc.$29.7M$31.4M$36.7M
Basic earnings per share$1$1$1
Basic earnings per share attributable to Core Laboratories Inc.$0.64$0.67$0.79
Diluted earnings per share$1$1$1
Diluted earnings per share attributable to Core Laboratories Inc.$0.63$0.66$0.77
Basic46.4M shares46.9M shares46.7M shares
Diluted47.0M shares47.7M shares47.5M shares

Compare Core Laboratories with another company

Corporate structure

Core Laboratories sits at the top of its group. 9 entities, 5 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Core Laboratories

  • ARIEL INVESTMENTS, LLC Filed SCHEDULE 13G/A on Core Laboratories, latest Aug 14, 2026 (5 filings since Feb 14, 2024)
  • DISCIPLINED GROWTH INVESTORS INC /MN Filed SCHEDULE 13G/A on Core Laboratories, latest Aug 14, 2026 (8 filings since Nov 14, 2024)
  • BlackRock Filed SCHEDULE 13G/A on Core Laboratories, latest Aug 6, 2026 (4 filings since Jun 8, 2023)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Core Laboratories, latest Mar 26, 2026 (5 filings since Jun 9, 2023)
  • EARNEST PARTNERS LLC Filed SCHEDULE 13G/A on Core Laboratories, latest Feb 12, 2026 (2 filings since Feb 14, 2024)
  • Core Laboratories Amstelveen, Netherlands
    • Core Laboratories (U.K.) Limited Subsidiary · United Kingdom
    • Core Laboratories (U.S.) Interests Holdings Inc. Subsidiary · Texas, United States
    • Core Laboratories Australia PTY LTD Subsidiary · Australia
    • Core Laboratories International B.V. Subsidiary · Netherlands
    • Core Laboratories Malaysia SDN BHD Subsidiary · Malaysia
    • Core Laboratories Sales B.V. Subsidiary · Netherlands
    • Owen Oil Tools LP Subsidiary · Delaware, United States
    • Saybolt Nederland B.V. Subsidiary · Netherlands

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Core Laboratories reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$10.4M9 Dec 31, 2025$10.4M9 Dec 31, 2024+0.1%
Buildings and improvements$123.5M9 Dec 31, 2025$117.7M9 Dec 31, 2024+5.0%
Machinery and equipment$286.2M9 Dec 31, 2025$283.3M9 Dec 31, 2024+1.0%
Property and equipment, before depreciation$420.2M9 Dec 31, 2025$411.4M9 Dec 31, 2024+2.1%
Accumulated depreciation$320.7M9 Dec 31, 2025$314.3M9 Dec 31, 2024+2.0%
Property and equipment, net$99.4M9 Dec 31, 2025$97.1M9 Dec 31, 2024+2.5%
Operating-lease assets (leased space)$54.3M9 Dec 31, 2025$56.5M9 Dec 31, 2024−3.8%

Real estate and locations

ItemLatestA year beforeChange
Stores709 Dec 31, 20257011 Dec 31, 20240%
Countries it operates in509 Dec 31, 20255011 Dec 31, 20240%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$22.7M9 Dec 31, 2025$19.2M9 Dec 31, 2024+18.5%
Stakes in other companies (equity method)$4.4M9 Dec 31, 2025$5.1M9 Dec 31, 2024−12.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$105.8M9 Dec 31, 2025$99.4M9 Dec 31, 2024+6.4%
Intangible assets, net (excluding goodwill)$7.1M9 Dec 31, 2025$6.4M9 Dec 31, 2024+11.2%
Accumulated amortization$19.5M9 Dec 31, 2025$19.3M9 Dec 31, 2024+1.1%

Inventory

ItemLatestA year beforeChange
Inventory, total$54.5M9 Dec 31, 2025$59.4M9 Dec 31, 2024−8.3%
Work in process$2.6M9 Dec 31, 2025$3.3M9 Dec 31, 2024−21.7%
Finished goods$25.0M9 Dec 31, 2025$27.1M9 Dec 31, 2024−8.0%

Properties, in its own words

Currently, we have over 70 offices (totaling approximately 2.9 million square feet of space) in more than 50 countries. In these locations, we lease approximately 1.4 million square feet and own approximately 1.5 million square feet. We serve our worldwide clients through five Advanced Technology Centers (“ATCs”) that are located in Aberdeen, Scotland; Abu Dhabi, United Arab Emirates; Houston, Texas; Kuala Lumpur, Malaysia; and Rotterdam, The Netherlands. The ATCs provide support for our more than 50 regional specialty centers located throughout the global energy producing provinces. In addition, our more significant manufacturing facilities are located in Frépillon, France, which is included in our Reservoir Description operating segment, Godley, Texas, Red Deer, Alberta, Canada, and Pyle, Wales, which are included in our Production Enhancement operating segment. Our facilities are adequate for our current operations; however, expansion into new facilities or the replacement or modification of existing facilities may be required to accommodate future growth.

Item 2 of the 10-K filed Mar 23, 2026.14

The story

The company’s specialties include basic rock properties, special core analysis, and PVT characterization of reservoir fluids. The company is a publicly traded company on NYSE under the symbol "CLB" and was founded in 1936. It is classified in the GCIS Sub-Industry: Oil & Gas Equipment & Services.

From Wikipedia’s article on Core Laboratories, shared under CC BY-SA 4.0.7

Leadership

Who has led Core Laboratories, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Lawrence Bruno2024–now

Chair

  1. Lawrence Bruno2024–now

Chief financial officer

  1. Richard L. Bergmark2007

Chief operating officer

  1. Monty L. Davis2007
197019801990200020102020
Board members and other officers (12)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Core Laboratories (U.K.) Limited London, United Kingdom8
  • Core Laboratories (U.S.) Interests Holdings Inc. Texas, United States8
  • Core Laboratories Australia PTY LTD Perth, Australia8
  • Core Laboratories International B.V. Amsterdam, The Netherlands8
  • Core Laboratories LP Delaware, United States8
  • Core Laboratories Malaysia SDN BHD Kuala Lumpur, Malaysia8
  • Core Laboratories Sales B.V. Rotterdam, The Netherlands8
  • Owen Oil Tools LP Delaware, United States8
  • Saybolt Nederland B.V. Rotterdam, The Netherlands8

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Core Laboratories Luxembourg S.A.Jan 17, 2023 to Feb 28, 20236

Timeline

  1. Aug 25, 20268-K Executive or director change29
  2. Jul 29, 20268-K Results of operations; Regulation FD disclosure30
  3. May 13, 20268-K Shareholder vote31
  4. Apr 29, 20268-K Results of operations; Regulation FD disclosure32
  5. Mar 23, 20268-K Regulation FD disclosure33
  6. Mar 17, 20268-K Results of operations34
  7. Mar 5, 20268-K Bylaws or fiscal year changed35
  8. Feb 4, 20268-K Results of operations; Regulation FD disclosure36
  9. Oct 22, 20258-K Results of operations; Regulation FD disclosure37
  10. Jul 23, 20258-K Entered a material agreement; Results of operations; New debt or obligation38
  11. May 27, 20258-K Shareholder vote39
  12. Apr 23, 20258-K Results of operations; Regulation FD disclosure40
  13. Jan 3, 2024New chief executive Lawrence Bruno becomes CEO15
  14. 1936Founded Founded1

Calendar

Coming up

  1. Oct 28, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.22 a share, on Oct 22, 2025.41

When it reported results

  1. Jul 29, 2026Reported quarterly or annual results30
  2. Apr 29, 2026Reported quarterly or annual results32
  3. Mar 17, 2026Reported quarterly or annual results34
  4. Feb 4, 2026Reported quarterly or annual results36
  5. Oct 22, 2025Reported quarterly or annual results37
  6. Jul 23, 2025Reported quarterly or annual results38
  7. Apr 23, 2025Reported quarterly or annual results40
  8. Jan 29, 2025Reported quarterly or annual results42

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

184 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 26 major events, 80 insider forms, 24 large holders, 41 other. The latest 20:

  1. Oct 5, 20264 EDGAR
  2. Oct 5, 20264 EDGAR
  3. Aug 25, 20268-K EDGAR
  4. Aug 14, 2026SCHEDULE 13G/A EDGAR
  5. Aug 14, 2026SCHEDULE 13G/A EDGAR
  6. Aug 6, 2026SCHEDULE 13G/A EDGAR
  7. Aug 4, 20264 EDGAR
  8. Aug 4, 20264 EDGAR
  9. Aug 4, 20264 EDGAR
  10. Jul 30, 202610-Q EDGAR
  11. Jul 29, 20268-K EDGAR
  12. Jun 29, 202611-K EDGAR
  13. May 15, 2026SD EDGAR
  14. May 15, 2026SCHEDULE 13G/A EDGAR
  15. May 13, 20268-K EDGAR
  16. May 4, 20264 EDGAR
  17. May 1, 202610-Q EDGAR
  18. Apr 29, 20268-K EDGAR
  19. Apr 8, 20264 EDGAR
  20. Apr 7, 20264 EDGAR

The 184 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 31, 2026Bruno LawrenceChairman and CEOBuy5,000$10.78$53.9KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Lawrence Bruno66$886.9K$5.0M48
2025Christopher S. Hill56$465.1K$1.9M48
2025Mark D. Tattoli54$407.9K$1.1M48
2025Gwendolyn Y. Gresham58$407.9K$1.1M48
2024ChairmanPresident and$886.9K$5.7M48
2024Senior Vice Presidentand$465.1K$2.2M48
2023Chief Executive Officer$886.9K$8.0M48
2023Chief Financial Officer$465.1K$2.9M48
2023Development and Investor Relations$407.9K$1.5M48
2023and General Counsel$407.9K$1.5M48

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Ariel Investments, LLC14,074,945$164.0M1.6%+904,557
BlackRock, Inc.7,460,118$86.9M0.0%+251,615
Disciplined Growth Investors Inc /mn3,042,177$35.4M0.6%−1,894,938
Earnest Partners LLC2,941,004$34.3M0.1%−114,992
State Street Corp2,176,480$25.4M0.0%+115,943
CWA Asset Management Group, LLC1,755,085$20.4M0.6%+14,084
Vanguard Capital Management LLC1,590,521$18.5M0.0%−29,342
Dimensional Fund Advisors LP1,548,203$18.0M0.0%+195,874
Schroder Investment Management Group1,543,638$16.9M0.0%New
Vanguard Portfolio Management LLC1,275,421$14.9M0.0%+20,585
Geode Capital Management, LLC1,193,824$13.9M0.0%+55,866
Gendell Jeffrey L1,090,973$12.7M0.1%+442,513
Heartland Advisors Inc1,058,311$12.3M0.5%+908,311
Goldman Sachs Group Inc751,643$8.8M0.0%−97,258
Evergreen Capital Management LLC669,508$7.8M0.1%New
Morgan Stanley656,146$7.6M0.0%+209,364
Northern Trust Corp608,202$7.1M0.0%+42,916
Charles Schwab Investment Management Inc565,065$6.6M0.0%−121,885
UBS Group AG461,777$5.4M0.0%+30,124
Fisher Asset Management, LLC447,949$5.2M0.0%−288,798
Bank of New York Mellon Corp401,283$4.7M0.0%−1,801
Van Eck Associates Corp393,682$4.6M0.0%−78,784
Citadel Advisors LLC371,615$4.3M0.0%+216,815
Vanguard Fiduciary Trust Co296,584$3.5M0.0%+7,022
Principal Financial Group Inc272,191$3.2M0.0%+370

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Core Laboratories is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCore Laboratories Inc. /DE/2
  • CIK0001958086
  • Employer ID (EIN)98-116419414
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company14
  • Incorporated inDelaware14
  • Fiscal year endsDecember 312
  • Industry code (SIC)1389 Oil & Gas Field Services, NEC2
  • SEC reviewing officeOffice of Energy & Transportation, Division of Corporation Finance2
  • Business address6316 Windfern Road, Houston, TX 770402
  • Phone713-328-26732
  • Shares outstanding45,884,542 as of Jul 24, 202613
  • Public float$498.9M as of Jun 30, 202514
  • AuditorKPMG LLP, Houston, TX PCAOB ID 185; it also attests to the company’s internal control over financial reporting14
  • On EDGAR sinceJan 17, 20232
  • Filings184 in all: 4 (72), 8-K (23), SCHEDULE 13G/A (17), 10-Q (10), S-8 POS (10), 4/A (5), 11-K (4), ARS (4)2
    All 27 form types

    DEFA14A (4), SD (4), 10-K (3), 3 (3), CORRESP (3), DEF 14A (3), SC 13G (3), SC 13G/A (3), 8-K/A (2), S-4/A (2), 424B3 (1), 425 (1), 8-K12B (1), EFFECT (1), NT 10-K (1), S-4 (1), S-8 (1), SCHEDULE 13G (1), UPLOAD (1)

  • Latest filingsAnnual report (10-K) Mar 23, 2026
    Quarterly report (10-Q) Jul 30, 2026
    Proxy statement (DEF 14A) Mar 31, 2026
    Latest 8-K (8-K) Aug 25, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock (par value $0.01)CLBNew York Stock Exchange

From the cover page of the 10-K filed Mar 23, 2026 (Section 12(b) of the Exchange Act).14

Risk factors and legal proceedings

The risks Core Laboratories names in Item 1A of its 10-K filed Mar 23, 2026: 28 risks under these headings, as written.14

  • Our forward-looking statements are based on assumptions that we believe to be reasonable but that may not prove to be accurate. All of our forward-looking information is, therefore, subject to risks and uncertainties that could cause actual results to differ materially from the results expected. All known material risks and uncertainties are discussed below.
  • Any cost reduction initiatives that Core Lab undertakes may not deliver the results it expects, and these actions may adversely affect its business.
  • Downturns in the oil and gas industry, or in the oilfield services business, or lower success rates of our clients’ exploration and drilling efforts, may have a material adverse effect on our financial condition or results of operations.
  • Conditions in the Middle East, including current uncertainty and instability resulting from the conflict between the United States, Israel and Iran, as well as other regional hostilities could adversely affect our business.
  • Changes in macro-economic factors impacting the oil and gas industry may negatively affect our ability to accurately predict client demand, which could cause us to hold excess or obsolete inventory and experience a reduction in gross margins and financial results.
  • We depend on the results of our international operations, which expose us to risks inherent in doing business abroad.
  • Our operations may be adversely affected by sanctions, export controls, and similar measures targeting Russia and other countries and territories as well as other responses to Russia’s military conflict in Ukraine.
  • Tariffs and other trade measures could adversely affect our business, results of operations, financial position and cash flows.
  • Our results of operations may be significantly affected by foreign currency exchange rate risk.
  • Our results of operations may be adversely affected because our efforts to comply with applicable anti-corruption laws such as the United States’ Foreign Corrupt Practices Act (the “FCPA”) and the United Kingdom’s Anti-Bribery Act (the “ABA”) could restrict our ability to do business in foreign markets relative to our competitors who are not subject to these laws.
  • If we are not able to develop or acquire new services or products or our services and products become technologically obsolete, our results of operations may be adversely affected.
  • If we are unable to obtain patents, licenses and other intellectual property rights covering our services and products, our operating results may be adversely affected.
The other 16 risks
  • We are subject to cyber security risks. A cyber incident could occur and result in information theft, data corruption, operational disruption and/or financial loss.
  • We are subject to the risk of supplier concentration.
  • There are risks relating to our acquisition strategy. If we are unable to successfully integrate and manage businesses that we have acquired and any businesses acquired in the future, our results of operations and financial condition could be adversely affected.
  • We may be unable to attract and retain skilled and technically knowledgeable employees, which could adversely affect our business.
  • We require a significant amount of cash to service our indebtedness, make capital expenditures, fund our working capital requirements and pay our dividend, and our ability to generate cash may depend on factors beyond our control.
  • We are subject to a variety of environmental and occupational safety and health laws and regulations, which may result in increased costs and significant liability to our business.
  • Legislative and regulatory initiatives relating to oil and gas development and the potential for related litigation could result in increased costs and additional operating restrictions or delays for our clients, which could reduce demand for our products or services.
  • We are subject to compliance with governmental regulations associated with climate change, energy conservation measures, or initiatives that stimulate demand for alternative forms of energy that could result in increased costs, limit the
  • areas in which our clients’ oil and natural gas production may occur and reduce demand for our services, which may adversely affect our business and results of operations.
  • Increasing attention to sustainability and corporate responsibility matters may impact our business.
  • We are subject to the physical effects of climate change, which may adversely affect our business and results of operations.
  • Provisions in our certificate of incorporation, bylaws and Delaware law may discourage a takeover attempt even if a takeover might be beneficial to our stockholders.
  • Our certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.
  • Our ability to maintain effective internal controls over financial reporting may be insufficient to allow us to accurately report our financial results or prevent fraud, and this could cause our financial statements to become materially misleading and adversely affect the trading price of our common stock.
  • The expected benefits of the Redomestication Transaction may not be realized.
  • If the Redomestication Transaction does not qualify as a “reorganization” under Section 368(a) of the U.S. Internal Revenue Code of 1986, as amended, Core Lab Shareholders may be required to pay U.S. federal income taxes.

Legal proceedings

See Note 12 - Commitments and Contingencies of the Notes to the Consolidated Financial Statements.

The opening of Item 3, Legal Proceedings.14

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48